oxytetracycline--anhydrous and melarsomine

oxytetracycline--anhydrous has been researched along with melarsomine* in 2 studies

Trials

1 trial(s) available for oxytetracycline--anhydrous and melarsomine

ArticleYear
Lack of resistance after re-exposure of cattle cured of Onchocerca ochengi infection with oxytetracycline.
    The American journal of tropical medicine and hygiene, 2007, Volume: 76, Issue:1

    Although vector control and ivermectin chemotherapy have led to a dramatic reduction in the incidence of river blindness (onchocerciasis), there is a consensus that additional control tools are required to sustain and extend this success. The recognition of endosymbiotic bacteria (Wolbachia) in filariae and their targeting by antibiotics constitutes the most significant and practicable opportunity for a macrofilaricidal therapy in the short-to-medium-term. Using Onchocerca ochengi in cattle, an analog of human onchocerciasis, we have previously shown that oxytetracycline is macrofilaricidal, and protective immunity exists naturally in a subset of animals termed putatively immune. Here, we report that although 24 weeks of weekly oxytetracycline treatment eliminated adult worms, cured animals remained susceptible to re-infection by natural challenge when compared with putatively immune cattle. However, their susceptibility was not significantly different from that of concurrently exposed, heavily infected animals. Thus, cattle cured by oxytetracycline are neither hypo-susceptible nor hyper-susceptible.

    Topics: Animals; Anthelmintics; Arsenicals; Cattle; Cattle Diseases; Disease Susceptibility; Female; Onchocerciasis; Oxytetracycline; Time Factors; Triazines

2007

Other Studies

1 other study(ies) available for oxytetracycline--anhydrous and melarsomine

ArticleYear
A worm's best friend: recruitment of neutrophils by Wolbachia confounds eosinophil degranulation against the filarial nematode Onchocerca ochengi.
    Proceedings. Biological sciences, 2011, Aug-07, Volume: 278, Issue:1716

    Onchocerca ochengi, a filarial parasite of cattle, represents the closest relative of the human pathogen, Onchocerca volvulus. Both species harbour Wolbachia endosymbionts and are remarkable in that adult female worms remain viable but sessile for many years while surrounded by host cells and antibodies. The basis of the symbiosis between filariae and Wolbachia is thought to be metabolic, although a role for Wolbachia in immune evasion has received little attention. Neutrophils are attracted to Wolbachia, but following antibiotic chemotherapy they are replaced by eosinophils that degranulate on the worm cuticle. However, it is unclear whether the eosinophils are involved in parasite killing or if they are attracted secondarily to dying worms. In this study, cattle infected with Onchocerca ochengi received adulticidal regimens of oxytetracycline or melarsomine. In contrast to oxytetracycline, melarsomine did not directly affect Wolbachia viability. Eosinophil degranulation increased significantly only in the oxytetracycline group; whereas nodular gene expression of bovine neutrophilic chemokines was lowest in this group. Moreover, intense eosinophil degranulation was initially associated with worm vitality, not degeneration. Taken together, these data offer strong support for the hypothesis that Wolbachia confers longevity on O. ochengi through a defensive mutualism, which diverts a potentially lethal effector cell response.

    Topics: Animals; Arsenicals; Cameroon; Cattle; Cattle Diseases; Cell Degranulation; Eosinophils; Gene Expression Regulation; Histological Techniques; Neutrophils; Onchocerca; Onchocerciasis; Oxytetracycline; Triazines; Wolbachia

2011